Table 2 Summary of Diversity Indexes and Sequence-Based Neutrality Tests in the Study Populations
Gene and Population No. of Chromosomes No. of Segregating Sites No. of Haplotypes HDa±SD πb ±SD θwc Tajima's D Fay and Wu's H
CD209:
 African 82 70 26 91.8 ± 1.6 26 ± 3.8 25.3 −.05 −19.45d
 European 86 18 14 79.6 ± 3.0 6.4 ± .6 6.5 −.04 −.26
 East Asian  86 12 11 56.7 ± 5.5 3.3 ± .5  4.3 −.65 −3.82d
  Total 254 79 42 84.5 ± 1.6 13 ± 1.7 23.3
CD209L:
 African 82 51 40 94.9 ± 1.2 16.1 ± .9 18.7 −.49 −1.52
 European 86 29 23 88.8 ± 1.9 17.7 ± 1.0 10.5 2.01e −.61
 East Asian  86 27 19 86.4 ± 1.8 16.0 ± .5  9.8 1.85d −.43
  Total 254 63 74 93.6 ± .7 17.7 ± .5 18.8
Note.—
The values shown in bold italics correspond to significant values for both the coalescence simulation and the empirical distribution (see the “Material and Methods” section). The analyses considered a total of 5,500 and 5,391 nucleotides for CD209 and CD209L, respectively.
a HD = haplotype diversity (%).
b Nucleotide diversity per base pair (×10−4).
c Watterson's estimator per base pair (×10−4).
d .02<P≤.05.
e P≤.02.